Glooko
PrivateLast Round
Series F
Oct 10, 2024
Est. Valuation
$420.88M
Total Funding Raised
$201M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Glooko is a healthtech company that provides a remote patient-monitoring and diabetes management platform designed to integrate data from diabetes devices and fitness wearables to provide actionable insights for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Health IoT, EHR & EMR, Healthcare Analytics, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Data as a Service, Revenue Share, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glooko Comparables
Compare Glooko with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tidepool | 78% | |
| Glytec | 77% | |
| Welldoc | 76% |
Glooko Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Oct 10, 2024 | ||||
| Series D | Mar 16, 2021 | ||||
| Series C | Jun 27, 2017 | ||||
| Series C | Sep 13, 2016 | ||||
| Series B | Mar 17, 2015 | ||||
Series A Extension | Jan 8, 2014 |
Key People
Founding team and executive leadership
Glooko Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgian | Series D, Series C, Series F |
| Lifeforce Capital | Series A Extension |
| Health Catalyst Capital Management | Series D |
| Realization Capital Partners | Series F |
| Social Capital | Series B, Series C, Series A, Seed, Series A Extension |
| Samsung NEXT Ventures | Series C |
| Cambrian | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Attending the 2026 AACE Annual Meeting in Las Vegas.
- Apr 14, 2026
Integrated digital health solution with NextGen's EHR system.
Recent news
Latest coverage and updates
- launchesSep 1, 2026
Glooko, Inc. launched GestationalCare module for Diabetes in pregnancy on Sep 1st '26.
- launchesSep 1, 2026
Glooko, Inc. introduces GestationalCare in Sep '26, a module that monitors gestational, Type 2, and Type 1 diabetes throughout pregnancy and supports pregnancy-specific clinical workflows.
- attends_eventJul 29, 2026
The Glooko, Inc. team is excited to join diabetes care and education specialists at the Association of Diabetes Care & Education Specialists' 2026 Annual Meeting in Ohio from Aug 7th to 10th '26.
Glooko Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Glooko's valuation, stock price, and market status.
Is Glooko a public or private company?
Glooko is a private company.
What is the current stock price of Glooko?
Glooko is a private company, so its shares have no public market price. Caplight tracks Glooko's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Glooko worth (valuation)?
Glooko's valuation is estimated at $420.9M based on funding round data.
Can I buy Glooko stock?
Glooko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Glooko's last funding round?
Glooko's most recent funding round was Series F on October 10, 2024.
Who are the main investors in Glooko?
Key investors in Glooko include Georgian, Health Catalyst Capital Management, Social Capital, Samsung Venture Investment, Canaan Partners.
Will Glooko IPO soon?
No public IPO plans have been announced for Glooko.
How can I track Glooko secondary market activity?
Caplight tracks bids, offers, and trades in Glooko's shares on secondary markets.